Interview 8 Oct 2019
Biotech Hubs: A Tale of Two Cities
…founded the online antibody provider Abcam in 1998. Under his leadership, the company grew to be worth over €2B today. Having met with success, Milner became an angel investor in…
Search Results for: Antibody candidate
News and Trends 18 May 2017
Spanish Biotech Clears €2.7M Funding Round for its New Stroke Drug
…comes in addition to Biogen’s Phase II antibody Natalizumab that blocks the recruitment of inflammatory cells. Similar to AptaTarget, French Acticor Biotech just raised €1.5M for its humanized antibody fragment…
Impacting vaccine development: COVID-19 and its implications for the future of vaccines
…the vaccination route and frequency, thus impacting the design of the immunization program. The breakthrough COVID-19 vaccines underwent the same checks and balances, with antibody detection methods of ELISA and…
News and Trends 1 Nov 2018
Llama Antibodies Could Be the Key to Universal Flu Prevention
…or different targets.” Indeed, the antibody developed by the group was built using four different llama antibodies, two targeting influenza A viruses and two targeting influenza B viruses to cover…
ADVERTISEMENT
News and Trends 25 Apr 2017
Novartis Negotiates its Way into the US Migraine Market
…drug candidates directed at Alzheimer’s and migraine, under which Amgen received the rights for the U.S., Canada, and Japan, while Novartis was left in charge of the residual markets. Now,…
News and Trends 2 Mar 2016
New Joint Venture to Shake Up Immuno-Oncology in the UK
…treatments both for solid tumours and leukaemias. This is not an unusual strategy. In the past, Amgen bought Micromet’s antibody constructs, and AstraZeneca acquired Spirogen and their antibody ‘warheads‘. And…
News and Trends 16 Dec 2022
Astellas gastric cancer drug meets phase 3 primary endpoint
…that includes capecitabine and oxaliplatin). Zolbetuximab is an investigational first-in-class claudin-18.2 (CLDN18.2) targeted monoclonal antibody, for the first-line treatment of patients with CLDN18.2-positive, HER2-negative, locally advanced unresectable or metastatic gastric…
News and Trends 24 Oct 2019
German Alzheimer’s Drug Backed with €43M After Biogen’s Surprise Turnaround
…an upcoming European phase IIb trial of Vivoryon’s lead candidate small molecule drug in around 250 patients with Alzheimer’s disease, the most common form of dementia. Results are expected in…
News and Trends 28 Feb 2018
Yet Another Checkpoint Inhibitor Goes to Trial with Bavarian Nordic’s Cancer Vaccine
…BMS’s Opdivo, an antibody binds to the PD-1 receptor, in late 2016. They also partnered with Roche to test CV301 with Roche’s Tecentriq, an antibody which binds to the ligand…
News and Trends 22 Jun 2022
Galapagos to acquire CellPoint and AboundBio to advance cell therapies
…an innovative, scalable, decentralized and automated point-of-care cell therapy supply model as well as a next-generation fully human antibody-based therapeutics platform. Galapagos said the goal is to expand the current…
News and Trends 11 Jul 2022
Financing round of $21M completed for drug to treat autoimmune diseases
…entered into the worldwide agreement for the investigational anti-CD38 monoclonal antibody, CID-103, for the treatment, prevention, and diagnosis of autoimmune diseases, conditions, and disorders in humans. Strong activity CID-103 is…
Interview 21 May 2020
What 2019 Can Teach About European Biotech Investments Going Forward
…the Nasdaq Stock Exchange. The Danish company Genmab also pulled off a €450M Nasdaq IPO to fund the development of its antibody drug pipeline. In addition to these huge fundraises,…
